实例探究 > From Waste To Fuel: Accelerating Synthetic Biology to reduce human carbon footprint

From Waste To Fuel: Accelerating Synthetic Biology to reduce human carbon footprint

公司规模
200-1,000
地区
  • America
  • Asia
  • Europe
国家
  • China
  • India
  • United States
产品
  • TeselaGen Platform
  • TeselaGen AI-enabled Platform
  • TeselaGen Lab Automation
技术栈
  • Machine Learning
  • Synthetic Biology
  • High-throughput Experimentation
实施规模
  • Enterprise-wide Deployment
影响指标
  • Digital Expertise
  • Innovation Output
  • Productivity Improvements
技术
  • 分析与建模 - 机器学习
  • 功能应用 - 远程监控系统
  • 平台即服务 (PaaS) - 应用开发平台
适用行业
  • 化学品
  • 可再生能源
  • 公用事业
适用功能
  • 商业运营
  • 产品研发
  • 质量保证
用例
  • 预测性维护
  • 过程控制与优化
  • 远程资产管理
服务
  • 数据科学服务
  • 软件设计与工程服务
  • 系统集成
关于客户
Founded in New Zealand in 2005, LanzaTech is now based in Illinois, USA, and employs more than 200 people, with locations in China, India, and Europe. LanzaTech is a global leader in gas fermentation, making sustainable fuels and chemicals via biological conversion of waste carbon emissions, including industrial off-gases, syngas generated from any biomass resource (e.g., municipal solid waste), organic industrial waste, and agricultural waste. LanzaTech’s expertise in fermentation scale-up, reactor design, machine learning, and synthetic biology has enabled the company to commercialize its recycling process and demonstrate the production of over 100 different chemicals. With global investors and partners, LanzaTech has a pipeline of commercial projects around the world and is working across the supply chain to provide novel circular solutions to mitigate carbon by producing consumer goods that would otherwise come from fresh fossil resources.
挑战
Lanzatech was manually creating instructions for lab-automation equipment, which is a difficult, error-prone, and time-consuming process. They needed to develop an in-house BioDesign system for DNA assembly, workflow automation, and data management. Additionally, they faced challenges in implementing high-throughput experimentation and developing complex genetic designs. Integration with other platforms and systems that Lanzatech was using was also a significant challenge.
解决方案
LanzaTech adopted the TeselaGen platform to address their challenges. TeselaGen provided an AI-enabled platform that improved and accelerated the success rate of complex designs. The platform allowed for the creation of over 1000 combinatorial DNA assembly designs, compared to the limit of around 10 when done manually. TeselaGen’s platform also integrated seamlessly with LanzaTech’s existing software and workflows, streamlining the lab-automation process. The platform offered features such as automated worklist generation, automated report generation, and automated workflow execution, which significantly reduced the time and errors associated with manual processes. Additionally, TeselaGen’s platform supported high-throughput experimentation and complex genetic designs, enabling LanzaTech to enhance their R&D capabilities.
运营影响
  • 100% user adoption of the TeselaGen platform by the LanzaTech team.
  • LanzaTech was able to easily integrate TeselaGen with their present software and workflows.
  • TeselaGen’s AI-enabled platform improved and accelerated the success rate of complex designs.
  • TeselaGen enhanced LanzaTech’s capacity to create 1000+ combinatorial DNA assembly designs, compared to the limit of ~10s when done manually.
  • Integrated and streamlined the lab-automation workflow through the TeselaGen platform.
数量效益
  • 100% user adoption of the TeselaGen platform.
  • Capacity to create 1000+ combinatorial DNA assembly designs.

Case Study missing?

Start adding your own!

Register with your work email and create a new case study profile for your business.

Add New Record

相关案例.

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 IoT ONE 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 IoT ONE 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。